Home/Pipeline/Biosimilar Development Programs

Biosimilar Development Programs

Oncology, Immunology

Development/Clinical TrialsActiveN/A

Key Facts

Indication

Oncology, Immunology

Phase

Development/Clinical Trials

Status

Active

Company

Torrent Pharmaceuticals

About Torrent Pharmaceuticals

Torrent Pharmaceuticals is a mission-driven, revenue-generating leader in the global branded generics market, focused on improving patient access to high-quality, complex medicines. Its core strategy of therapeutic area specialization and geographic diversification has yielded market leadership in India, Brazil, and Germany, supported by a robust manufacturing and R&D infrastructure. The company is executing a growth strategy centered on expanding its portfolio of complex generics, biosimilars, and consumer healthcare brands while maintaining a strong commitment to sustainability and ESG principles.

View full company profile

Therapeutic Areas

Cardiovascular Central Nervous System Gastro-Intestinal Women's Healthcare Diabetology Oncology Nephrology Anti-Microbial

Other Oncology, Immunology Drugs

Drug	Company	Phase	Status
Biosimilars Portfolio	lupin	Various	Development
Internal Antibody Discovery Programs	Biocytogen	Pre-clinical	Active
Biosimilars Pipeline	Alkem Laboratories	Development / Clinical Trials	Active
Generic Biologics Pipeline	Gland Pharma	Development	Active
CDMO: Complex Small Molecules	EuroAPI	Preclinical to Phase III	Development & Manufacturing